Replies to post #480 on Neptune Wellness Solutions Inc (NEPT)

[FUNMAN]

Complete release and comments - Nice find GE!

This buildout to 200,000 kg is a baby step in comparison to their intentions. I believe, with the completion of Phase IIIa which will
bring total annual extraction capacity to 1,500,000 kg, their plan calls for them to have a bigger facility than Medipharm and Valens.

"With our diverse base of 100+ customers across North America in multiple verticals..."

I love the broad customer base. Instead of relying on one giant partner. A large customer base reduces risk when one of them takes their business elsewhere or goes out of business.

Their North Carolina facility should not be discounted. It will be accretive this year.

Neptune Achieves a Milestone with Completion of Phase II Expansion
Sherbrooke facility to reach annual run-rate of 200,000 kg by the end of November

Laval, Québec, CANADA – October 16, 2019 – Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT) is pleased to announce that its Sherbrooke, Quebec facility started to process biomass using its new cold ethanol equipment. The first shipments of
cannabis extracts produced with our ethanol equipment are expected in the coming weeks once the final release testing is completed on the first batches that have been extracted. Combined with Neptune’s CO2 extraction line, the Company’s capacity to process biomass is expected to reach an annual run rate of 200,000 kg by the end of November. As indicated previously, Neptune’s current capacity, including the phase II expansion, is fully committed to existing clients.

Starting with Phase II and going forward, Neptune has opted for cold ethanol technology, which could be up to 5x faster than our CO2 equipment and which consumes up to 2x less energy than our CO2 technology. Our cold ethanol process combined with the high level of automation of Neptune’s Sherbrooke facility should position the Company as a low-cost manufacturer in Canada.

Additionally, in recent weeks, we have received additional security clearance from Health Canada for our production personnel which should alleviate operational constraints.

“The Phase II cold ethanol production was completed on budget and is another important milestone in our capacity expansion strategy. We are currently working on Phase IIIa which will bring total annual extraction capacity to 1,500,000 kg. This capacity expansion is necessary to
support the execution of Neptune’s growth strategy to become a global leader in cannabis extraction and purification while meeting the growing demand from consumers for natural products. With our diverse base of 100+ customers across North America in multiple verticals, including legal cannabis and hemp, nutraceutical, and consumer packaged goods, Neptune is well positioned to execute on its growth plans,” said Michael Cammarata, Neptune’s CEO.

About Neptune Wellness Solutions Inc.

Neptune Wellness Solutions specializes in the extraction, purification and formulation of health and wellness products. The Company has in excess of 100 customers across several verticals including legal cannabis and hemp, nutraceutical and CPG. Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc., is licensed by Health Canada to process cannabis at its 50,000-squarefoot facility located in Sherbrooke, Quebec. The Company also has a 24,000 square-foot facility
located in North Carolina to process hemp biomass into extracts. Neptune brings decades of experience in the natural products sector to the legal cannabis and hemp industries. Leveraging its scientific and technological expertise, the Company sees applications for hemp-derived
extracts in the U.S. beyond existing markets and product forms and into personal care and home care markets. Neptune’s activities also include the development and commercialization of turnkey nutrition solutions and patented ingredients such as MaxSimil®, and a variety of marine and seed oils. Its head office is located in Laval, Quebec.


Forward Looking Statements

Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements” within the meaning of the U.S. securities laws and Canadian securities laws. Such forward-looking statements involve known and unknown risks,
uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes", "belief", "expects", "intends", “projects”, "anticipates", "will", "should", "likely" or "plans" to be
uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.

The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement and the “Cautionary Note Regarding Forward-Looking Information” section contained in Neptune’s latest Annual Information Form (the “AIF”), which
also forms part of Neptune’s latest annual report on Form 40-F, and which is available on SEDAR at www.sedar.com, on EDGAR at www.sec.gov/edgar.html and on the investor section of Neptune’s website at www.neptunecorp.com. All forward-looking statements in this press release are made as of the date of this press release. Neptune does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in Neptune public securities filings with the Securities and Exchange Commission and the Canadian securities
commissions. Additional information about these assumptions and risks and uncertainties is contained in the AIF under “Risk Factors”.
Neither NASDAQ nor the Toronto Stock Exchange accepts responsibility for the adequacy or accuracy of this release.

[FUNMAN]

Neptune Wellness Solutions Inc (NASDAQ:NEPT) Stake Lifted by Jane Street Group LLC
Posted by William Tyler on Oct 16th, 2019

Jane Street Group LLC increased its stake in shares of Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSE:NTB) by 45.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,598 shares of the biotechnology company’s stock after buying an additional 7,106 shares during the quarter. Jane Street Group LLC’s holdings in Neptune Wellness Solutions were worth $98,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of NEPT. Signition LP bought a new position in Neptune Wellness Solutions during the 2nd quarter worth $87,000. Morgan Stanley grew its stake in Neptune Wellness Solutions by 9.1% during the 2nd quarter. Morgan Stanley now owns 208,980 shares of the biotechnology company’s stock worth $909,000 after buying an additional 17,361 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in Neptune Wellness Solutions by 265.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 9,929 shares of the biotechnology company’s stock worth $43,000 after buying an additional 7,214 shares during the last quarter. Finally, Wells Fargo & Company MN grew its stake in Neptune Wellness Solutions by 19.4% during the 2nd quarter. Wells Fargo & Company MN now owns 15,362 shares of the biotechnology company’s stock worth $67,000 after buying an additional 2,500 shares during the last quarter. Hedge funds and other institutional investors own 11.85% of the company’s stock.

Shares of NEPT stock opened at $3.47 on Wednesday. Neptune Wellness Solutions Inc has a 1 year low of $2.42 and a 1 year high of $6.57. The stock has a fifty day moving average of $3.89 and a two-hundred day moving average of $4.28. The firm has a market capitalization of $320.81 million, a PE ratio of -24.79 and a beta of 1.84.

Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last announced its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.03) by ($0.03). Neptune Wellness Solutions had a negative return on equity of 23.18% and a negative net margin of 107.62%. The business had revenue of $3.26 million for the quarter, compared to analyst estimates of $4.51 million. As a group, analysts predict that Neptune Wellness Solutions Inc will post 0.01 EPS for the current year.

A number of brokerages recently commented on NEPT. ValuEngine upgraded Neptune Wellness Solutions from a “hold” rating to a “buy” rating in a research note on Thursday, September 19th. Echelon Wealth Partners restated a “buy” rating on shares of Neptune Wellness Solutions in a research note on Wednesday, July 24th. BidaskClub downgraded Neptune Wellness Solutions from a “sell” rating to a “strong sell” rating in a research note on Friday, September 20th. Finally, Zacks Investment Research downgraded Neptune Wellness Solutions from a “hold” rating to a “sell” rating in a research note on Wednesday, September 25th.

About Neptune Wellness Solutions

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.